MX2022014200A - Derivado de 1,4,5,6-tetrahidropirimidin-2-amina. - Google Patents
Derivado de 1,4,5,6-tetrahidropirimidin-2-amina.Info
- Publication number
- MX2022014200A MX2022014200A MX2022014200A MX2022014200A MX2022014200A MX 2022014200 A MX2022014200 A MX 2022014200A MX 2022014200 A MX2022014200 A MX 2022014200A MX 2022014200 A MX2022014200 A MX 2022014200A MX 2022014200 A MX2022014200 A MX 2022014200A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- group
- hydrogen atom
- tetrahydropyrimidine
- amine derivative
- Prior art date
Links
- PEHDFSFYZKSKGH-UHFFFAOYSA-N 1,4,5,6-tetrahydropyrimidin-2-amine Chemical class NC1=NCCCN1 PEHDFSFYZKSKGH-UHFFFAOYSA-N 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020085420 | 2020-05-14 | ||
| PCT/JP2021/018252 WO2021230325A1 (ja) | 2020-05-14 | 2021-05-13 | １，４，５，６－テトラヒドロピリミジン－２－アミン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022014200A true MX2022014200A (es) | 2022-12-07 |
Family
ID=78524455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022014200A MX2022014200A (es) | 2020-05-14 | 2021-05-13 | Derivado de 1,4,5,6-tetrahidropirimidin-2-amina. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230192661A1 (https=) |
| EP (1) | EP4151632A4 (https=) |
| JP (1) | JP7661969B2 (https=) |
| KR (1) | KR20230011967A (https=) |
| CN (1) | CN115551846B (https=) |
| AU (1) | AU2021270095A1 (https=) |
| BR (1) | BR112022023058A2 (https=) |
| CA (1) | CA3182964A1 (https=) |
| MX (1) | MX2022014200A (https=) |
| WO (1) | WO2021230325A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023085396A1 (ja) * | 2021-11-12 | 2023-05-19 | Ｕｂｅ株式会社 | アルポート症候群を治療または予防するための医薬組成物 |
| EP4733297A1 (en) * | 2023-06-22 | 2026-04-29 | Antibody Therapeutics, Inc. | Integrin-inhibiting small molecule compound |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123164A (en) | 1995-08-30 | 2001-03-19 | Searle & Co | Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them |
| ZA994406B (en) | 1998-03-04 | 2000-02-11 | Searle & Co | Meta-azacyclic amino benzoic acid and derivatives thereof. |
| US6372719B1 (en) | 1998-03-04 | 2002-04-16 | Jay Cunningham | ανβ3 integrin antagonists in combination with chemotherapeutic agents |
| KR20010042614A (ko) * | 1998-04-10 | 2001-05-25 | 윌리암스 로저 에이 | 비트로넥틴 길항제로서 복소환식 글리실 베타-알라닌 유도체 |
| JP2006514050A (ja) * | 2002-12-20 | 2006-04-27 | ファルマシア・コーポレーション | インテグリン受容体アンタゴニスト誘導体としてのβ−アミノ酸化合物のＲ異性体 |
| WO2014015054A1 (en) * | 2012-07-18 | 2014-01-23 | Saint Louis University | Beta amino acid derivatives as integrin antagonists |
| US8716226B2 (en) | 2012-07-18 | 2014-05-06 | Saint Louis University | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists |
| SG11201805387RA (en) | 2015-12-30 | 2018-07-30 | Univ Saint Louis | Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists |
-
2021
- 2021-05-13 KR KR1020227042726A patent/KR20230011967A/ko active Pending
- 2021-05-13 AU AU2021270095A patent/AU2021270095A1/en active Pending
- 2021-05-13 JP JP2022522202A patent/JP7661969B2/ja active Active
- 2021-05-13 MX MX2022014200A patent/MX2022014200A/es unknown
- 2021-05-13 CN CN202180034572.XA patent/CN115551846B/zh active Active
- 2021-05-13 US US17/924,942 patent/US20230192661A1/en active Pending
- 2021-05-13 WO PCT/JP2021/018252 patent/WO2021230325A1/ja not_active Ceased
- 2021-05-13 CA CA3182964A patent/CA3182964A1/en active Pending
- 2021-05-13 BR BR112022023058A patent/BR112022023058A2/pt unknown
- 2021-05-13 EP EP21803967.5A patent/EP4151632A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115551846B (zh) | 2024-03-08 |
| JP7661969B2 (ja) | 2025-04-15 |
| EP4151632A4 (en) | 2024-04-24 |
| CA3182964A1 (en) | 2021-11-18 |
| AU2021270095A1 (en) | 2022-12-22 |
| JPWO2021230325A1 (https=) | 2021-11-18 |
| EP4151632A1 (en) | 2023-03-22 |
| WO2021230325A1 (ja) | 2021-11-18 |
| US20230192661A1 (en) | 2023-06-22 |
| KR20230011967A (ko) | 2023-01-25 |
| BR112022023058A2 (pt) | 2022-12-20 |
| CN115551846A (zh) | 2022-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY203060A (en) | Prophylactic or therapeutic agent for spinal muscular atrophy | |
| MX2022008722A (es) | Derivados de arilamida con actividad antitumoral. | |
| MX373120B (es) | Compuestos utiles para tratar sida. | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| MY198568A (en) | Polycyclic carbamoylpyridone derivative | |
| NO20073956L (no) | Pyrazolderivater for inhibering av CDK og GSK | |
| MX2009005731A (es) | Composicion antimicrobiana para acabado de textiles. | |
| MX2022014200A (es) | Derivado de 1,4,5,6-tetrahidropirimidin-2-amina. | |
| WO2003080580A3 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
| NO20083868L (no) | IAP BIR domenebindende forbindelser | |
| MY203593A (en) | Polycyclic pyridone derivative | |
| ID25649A (id) | Turunan-turunan sikloalkena, produksi serta penggunaannya | |
| MY206124A (en) | Pyrimidine compound or salt thereof | |
| EP4464334A3 (en) | Use of compounds for treating hk2-expressing cancers | |
| MX2023010125A (es) | Inhibidores del sarcomero cardiaco. | |
| PH12022550255A1 (en) | 2-aminoquinazolinone derivative | |
| MX2023009045A (es) | Derivados novedosos de pirimidin-2-il sulfonamida. | |
| MX2025001765A (es) | Derivados deuterados de pirimidin-2-il sulfonamida | |
| AU2006325931A8 (en) | Amine compound and use thereof for medical purposes | |
| ES354601A1 (es) | Procedimiento para la obtencion de colorantes antraquinoni-cos reactivos. | |
| SA118390677B1 (ar) | مشتقات ثنائي هيدرو بيريميدينون | |
| MX2013005179A (es) | Derivado de pirazino[2,3-d]isoxazol. | |
| WO2019182746A3 (en) | Catalyst formulations | |
| TW200517394A (en) | Method for stabilization of diarylvinylene compounds | |
| AU7798687A (en) | 4-substituted cyclohexylamine derivatives, fungicides containing these and a method of controlling fungi |